Mohali unit news - Livemint
Livemint

|E-Paper

×
Home Elections 2018 Companies Industry Politics Money Opinion LoungeMultimedia Science Education Sports TechnologyConsumerSpecials
×
Home » Mohali unit

Search Results for Mohali unit »

News Videos Slideshows
Shares of pharma firms, including Dr Reddy’s, Wockhardt, Sun Pharma, Aurobindo Pharma, Lupin and Cipla, plunged on Tuesday after the US FDA imposed an import ban on a Divi’s Labs unit in Visakhapatnam. Graphic: Subrata Jana/Mint

Wed, Mar 22 2017. 12 39 AM IST

Pharma stocks take a beating on renewed US FDA scrutiny

Divi’s Lab and Dr. Reddy’s troubles with US FDA indicate Indian pharma firms face a long and uphill struggle to meet quality standards in world’s largest drug market

On Thursday, shares of Sun Pharma ended up 1.75% at Rs675.55 on the BSE after falling 6% on Wednesday. Photo: Mint

Thu, Dec 08 2016. 07 32 PM IST

Sun Pharma says US FDA made 9 observations at Halol unit

Sun Pharma said that none of the observations were repeat observations, which eases concerns over an import alert from the US FDA for the plant

Sun Parma’s Halol plant received a warning letter last year from the US FDA due to past violations, which prevented new product launches from the facility in the US, the company’s largest market. Photo: Mint

Wed, Dec 07 2016. 01 20 PM IST

US FDA finds breaches at Sun Pharma’s Halol plant again

US FDA has given a 14-page inspection report on Sun Pharma’s Halol plant that could list potential violations of the agency’s manufacturing guidelines

Sun Pharmaceutical Industries Inc, the US arm of drug major Sun Pharma is recalling 3,26,103 bottles of Kenalog (Triamcinolone Acetonide) spray with spray tube topical Aerosol on account of failed stability specifications. Photo: Mint

Wed, Nov 30 2016. 08 39 PM IST

Sun Pharma, Cadila Healthcare recall products from US market

Zydus Pharmaceuticals USA is recalling 2,472 units of Bupropion Hydrochloride extended release tablets manufactured by Ahmedabad-based Cadila Healthcare

Photo: Madhu Kapparath/Mint

Fri, Nov 25 2016. 07 54 AM IST

Opening bell | Asian markets open higher; RIL, Sun Pharma, Spicejet in news

French bank BNP Paribas SA on Thursday said it has completed the acquisition of brokerage Sharekhan

Sun Pharma’s corporate office in Mumbai. The Mohali facility belonged to Ranbaxy Laboratories before Sun Pharma acquired the firm. Photo: Mint

Thu, Nov 24 2016. 08 51 PM IST

Sun Pharma’s Mohali unit violated manufacturing norms, finds US FDA

US FDA found breaches of manufacturing standards at Sun Pharma’s Mohali plant during the 7-16 November visit

Both Ranbaxy and Wockhardt have hired independent consultants to help them emerge from the regulatory bind and follow the FDA’s current good manufacturing practices.

Mon, Oct 21 2013. 12 23 AM IST

FDA ban leads to job losses at Ranbaxy, Wockhardt

Ranbaxy, Wockhardt fire 5% of shopfloor workforce following action by US regulator for violating norms

1